首页|无创正压通气在重症支气管哮喘合并呼吸衰竭急诊治疗中的效果评价

无创正压通气在重症支气管哮喘合并呼吸衰竭急诊治疗中的效果评价

扫码查看
目的 观察无创正压通气在重症支气管哮喘合并呼吸衰竭急诊治疗中的效果.方法 62例重症支气管哮喘合并呼吸衰竭患者,遵循双盲随机分组原则分为对照组和实验组,各 31 例.两组患儿均给予常规治疗,对照组在常规治疗基础上采用有创正压通气治疗,实验组在常规治疗基础上采用无创正压通气治疗.比较两组患者基本生命指征、炎症指标、血气分析指标、并发症发生情况.结果 治疗 24 h后,实验组心率(96.65±7.14)次/min低于对照组的(112.32±7.11)次/min,收缩压(125.65±4.67)mm Hg(1 mm Hg=0.133 kPa)、舒张压(85.45±3.54)mm Hg均高于对照组的(120.54±4.69)、(73.16±3.51)mm Hg(P<0.05).治疗 24 h后,实验组C反应蛋白、白细胞介素-6、白细胞介素-17 分别为(8.54±1.43)mg/L、(114.54±24.65)pg/ml、(3.54±0.15)ng/L,低于对照组的(15.24±1.47)mg/L、(148.65±24.61)pg/ml、(5.24±0.11)ng/L(P<0.05).治疗 24 h后,实验组动脉血氧分压(80.14±3.03)mm Hg、动脉血氧饱和度(94.56±1.56)%均高于对照组的(73.26±3.06)mm Hg、(87.21±1.52)%,动脉血二氧化碳分压(40.24±3.61)mm Hg低于对照组的(46.18±3.64)mm Hg(P<0.05).治疗 24 h后,实验组第 1 秒用力呼气容积、第 1 秒用力呼气容积与用力肺活量的比值、每分钟通气量分别为(1265.54±21.31)ml、(82.56±5.71)%、(7.73±0.62)L,均大于对照组的(1043.26±21.27)ml、(75.61±5.72)%、、(5.25±0.59)L(P<0.05).实验组并发症发生率 9.68%低于对照组的 32.26%(P<0.05).结论 重症支气管哮喘合并呼吸衰竭患者急诊治疗中应用无创正压通气可显著提升临床效果.
Effect evaluation of non-invasive positive pressure ventilation in emergency treatment of severe bronchial asthma complicated with respiratory failure
Objective To observe the effect of non-invasive positive pressure ventilation in emergency treatment of severe bronchial asthma complicated with respiratory failure.Methods 62 patients with severe bronchial asthma complicated with respiratory failure were divided into a control group and an experimental group according to the principle of double-blind randomization,with 31 cases in each group.Children in both groups were given conventional treatment,on this basis,the control group was treated with invasive positive pressure ventilation,and the experimental group was treated with non-invasive positive pressure ventilation.The basic vital signs,inflammatory markers,blood gas analysis indicators and complications were compared between the two groups.Results After 24 h of treatment,the experimental group had lower heart rate of(96.65±7.14)beats/min than(112.32±7.11)beats/min in the control group;the experimental group had systolic blood pressure of(125.65±4.67)mm Hg(1 mm Hg=0.133 kPa)and diastolic blood pressure of(85.45±3.54)mm Hg,which were higher than(120.54±4.69)and(73.16±3.51)mm Hg in the control group(P<0.05).After 24 h of treatment,the C-reactive protein,interleukin-6 and interleukin-17 in the experimental group were(8.54±1.43)mg/L,(114.54±24.65)pg/ml and(3.54±0.15)ng/L,which were lower than(15.24±1.47)mg/L,(148.65±24.61)pg/ml and(5.24±0.11)ng/L in the control group(P<0.05).After 24 h of treatment,the experimental group had arterial partial pressure of oxygen of(80.14±3.03)mm Hg and the arterial oxygen saturation of(94.56±1.56)%,which were higher than(73.26±3.06)mm Hg and(87.21±1.52)%in the control group;the experimental group had lower arterial partial pressure of carbon dioxide of(40.24±3.61)mm Hg than(46.18±3.64)mm Hg in the control group(P<0.05).After 24 h of treatment,the forced expiratory volume in one second,the ratio of forced expiratory volume in one second to forced vital capacity,and the minute ventilation volume were(1265.54±21.31)ml,(82.56±5.71)%,and(7.73±0.62)L,which were higher than(1043.26±21.27)ml,(75.61±5.72)%,and(5.25±0.59)L in the control group(P<0.05).The complication rate of 9.68%in the experimental group was lower than 32.26%in the control group(P<0.05).Conclusion The application of non-invasive positive pressure ventilation in the emergency treatment of severe bronchial asthma complicated with respiratory failure can significantly improve the clinical effect.

Non-invasive positive pressure ventilationSevere bronchial asthmaRespiratory failureEmergency treatment

王法

展开 >

110300 辽宁省新民市人民医院

无创正压通气 重症支气管哮喘 呼吸衰竭 急诊治疗

2024

中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
年,卷(期):2024.19(8)
  • 12